Page 3 - Paul Estrem News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Paul estrem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Paul Estrem Today - Breaking & Trending Today

Monopar and NorthStar Announce Patent Filing on Promising Radiopharmaceutical Discovery


Monopar and NorthStar Announce Patent Filing on Promising Radiopharmaceutical Discovery
Font : A-A+
WILMETTE, Ill. and BELOIT, Wis., May 24, 2021 (GLOBE NEWSWIRE) Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, today announced the filing of a provisional patent with the U.S. Patent and Trademark Office (USPTO) titled “Bio-Targeted Radiopharmaceutical Compositions Containing Ac-225 and Methods of Preparation.” Radiopharmaceutical therapy is a promising approach to treat cancer and other diseases using radioactive metals bound with proteins/antibodies to target and kill cells. Actinium-225 (Ac-225) is emerging as a radioactive isotope of choice for radiopharmaceuticals due to favorable properties such as its long half-life, high potency, and induction of localized cell death. ....

United States , Paul Estrem , Alisa Holst , James Harvey , Kimr Tsuchimoto , Priscilla Harlan , Andrew Mazar , Exchange Commission , Trademark Office , Monopar Therapeutics Inc , Northstar Medical Radioisotopes , Chief Scientific Officer , Star Medical Radioisotopes , Drug Administration , Private Securities Litigation Reform Act , Investor Relations , Chief Financial Officer , Senior Vice President , Vice President Sales , Us Patent And Trademark Office , Io Targeted Radiopharmaceutical Compositions , C 225 , Ealth Press Release , ஒன்றுபட்டது மாநிலங்களில் , லிசா ஹோல்ஸ்ட் , ஜேம்ஸ் ஹார்வி ,

Monopar and NorthStar Announce Patent Filing on Promising Radiopharmaceutical Discovery


Share:
WILMETTE, Ill. and BELOIT, Wis., May 24, 2021 (GLOBE NEWSWIRE) Monopar Therapeutics Inc. (NASDAQ:MNPR) and NorthStar Medical Radioisotopes, LLC, today announced the filing of a provisional patent with the U.S. Patent and Trademark Office (USPTO) titled Bio-Targeted Radiopharmaceutical Compositions Containing Ac-225 and Methods of Preparation. Radiopharmaceutical therapy is a promising approach to treat cancer and other diseases using radioactive metals bound with proteins/antibodies to target and kill cells. Actinium-225 (Ac-225) is emerging as a radioactive isotope of choice for radiopharmaceuticals due to favorable properties such as its long half-life, high potency, and induction of localized cell death. ....

United States , Paul Estrem , Alisa Holst , James Harvey , Kimr Tsuchimoto , Priscilla Harlan , Andrew Mazar , Exchange Commission , Trademark Office , Monopar Therapeutics Inc , Northstar Medical Radioisotopes , Chief Scientific Officer , Star Medical Radioisotopes , Drug Administration , Private Securities Litigation Reform Act , Vice President , Chief Financial , President Sales , ஒன்றுபட்டது மாநிலங்களில் , லிசா ஹோல்ஸ்ட் , ஜேம்ஸ் ஹார்வி , ப்ரிஸில ஹார்லன் , ஆண்ட்ரூ மசார் , பரிமாற்றம் தரகு , முத்திரை அலுவலகம் , தலைமை அறிவியல் அதிகாரி ,